# When does an aching joint need an exam? *When Joint Soreness Needs Care | Orthobiologics Mesa* > Orthobiologics Mesa explains blood-based joint care, when an ongoing ache deserves an exam, urgent warning signs, and what the visit includes. You can learn here when joint soreness needs medical attention. A busy day can cause an ache that settles with rest. Pain that keeps returning, new weakness, or lost movement deserves a closer look. You don't need to know the cause before booking an exam. Write down the day the trouble became clear and which movements hurt. Add any swelling or sleep loss to your notes. Those facts give the clinician a useful starting point. ## When is it time for a regular visit? Arrange an exam when the joint limits normal daily tasks. You may walk less, avoid steps, or struggle to reach. Soreness that doesn't ease with rest and gentle motion also deserves review, especially when swelling returns. The clinician will ask where the joint hurts and what starts it. You may bend, straighten, or turn the sore area. The exam checks tenderness, swelling, strength, and movement. An X-ray may help when the cause or wear isn't clear. ## Which warning signs can't wait? A fever beside joint warmth and swelling calls for care today. After a fall, prompt help matters if the joint looks out of shape. Go quickly if your leg can't hold your weight. New bladder or bowel trouble with weakness or numbness is urgent. Spreading redness, warmth, and fever after a procedure may mean infection. Fast worsening, unexplained weight loss, or pain during sleep also needs review. These symptoms need ordinary medical care before a planned joint procedure, because the cause must be checked first. ## What will happen during the exam? The visit starts with the sore joint and its likely cause. The clinician reviews your health, medicines, earlier care, and goals. You'll discuss possible benefit, risk, cost, and other choices. Ask why one choice fits the exam better than another. Blood-based care aims for less soreness and easier movement without surgery. QC Kinetix offers biologic therapies, meaning medical providers draw your blood, prepare it there, and use it at the sore joint. Results differ, so the team may advise testing or different care. You may leave without needing a procedure. ## Sources 1. The ESSKA-ORBIT European consensus on blood-derived orthobiologics graded 28 question-statement sets; only 9 of 28 had high-level scientific support. Three statements reached grade A: that there is enough preclinical and clinical evidence to support PRP use in knee OA; that clinical evidence shows effectiveness in MILD TO MODERATE knee OA (KL grade 3 or lower); and that PRP provides a longer effect than the short-term effect of corticosteroid with a safer profile. The panel regarded PRP as a valid and possible first-line injectable option for KL grades 1-3. Laver L, et al. — [The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma).](https://pubmed.ncbi.nlm.nih.gov/38436492/). *Knee Surgery, Sports Traumatology, Arthroscopy*, 2024. DOI: 10.1002/ksa.12077. 2. The companion ESSKA-ORBIT consensus on cell-based therapy (77 experts, 22 countries, 27 statements) found only 5 of 27 statements reached recommendation level A or B; 22 were rated C or D. It concluded that cell-based therapy shows clinical benefit in pain and function up to 12 months for KL grades 1-3 with some benefit in selected KL 4, but that because of limited high-quality studies and NO clear superiority over other injectables it should be considered a SECOND-LINE option, after other non-operative treatment fails. de Girolamo L, et al. — [The use of injectable orthobiologics for knee osteoarthritis: A formal ESSKA-ORBIT consensus. Part 2-Cell-based therapy.](https://pubmed.ncbi.nlm.nih.gov/40923345/). *Knee Surgery, Sports Traumatology, Arthroscopy*, 2025. DOI: 10.1002/ksa.70001. 3. A phase III double-blind placebo-controlled trial of a SINGLE injection of culture-expanded autologous adipose-derived MSCs in 261 patients with KL grade 3 knee OA found significantly better VAS pain (25.2 vs 15.5 mm improvement; P=.004) and total WOMAC (21.7 vs 14.3; P=.002) at 6 months versus placebo, with no serious treatment-related adverse events - but MRI showed NO significant difference in cartilage-defect change between groups. Culture-expanded cells of this kind are a drug in the United States and are not available outside a trial. Kim KI, et al. — [Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial.](https://pubmed.ncbi.nlm.nih.gov/37345256/). *American Journal of Sports Medicine*, 2023. DOI: 10.1177/03635465231179223. 4. The 2025 Cochrane review of stem cell injections for knee osteoarthritis pooled 25 randomised trials (1,341 participants) and found that, compared with placebo injection, stem cell injection MAY slightly improve pain (1.2 points better on a 0-10 scale, 7 studies, 445 participants) and function (14.2 points better on a 0-100 scale, 7 studies, 432 participants) up to six months - both rated LOW-certainty evidence, downgraded for indirectness (cell source, preparation and dose varied across studies) and suspected publication bias, since up to three larger RCTs were conducted and withdrawn before reporting results. Radiographic progression was not assessed in any included study. Whittle SL, et al. — [Stem cell injections for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/40169165/). *Cochrane Database of Systematic Reviews*, 2025. DOI: 10.1002/14651858.CD013342.pub2. 5. A meta-analysis of 24 RCTs (1,653 participants) with plantar fasciitis found PRP produced significantly better VAS pain than corticosteroid at 3 and 6 months but not at 1 month or 12 months, and better AOFAS function scores at 3, 6 and 12 months. Plantar fascia thickness did not differ significantly at any time point. Zuo A, et al. — [Platelet-Rich Plasma Versus Corticosteroids in the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39778212/). *American Journal of Physical Medicine & Rehabilitation*, 2025. DOI: 10.1097/PHM.0000000000002677. ## Would an exam help you choose what comes next? A visit can cover the cause of your soreness, earlier care, daily limits, and choices without surgery. The exam may show that different care fits better. Book a free consultation: --- Know why it hurts and what may help. Learn what may cause an aching joint, ways to settle it, signs needing care, blood procedures, and local routes. Plain help with aching joints, care choices, warning signs, and nearby office routes. This site is operated by the owners of the QC Kinetix clinics serving the Phoenix area, including the Chandler and Scottsdale offices referenced here; the business can benefit when readers book. Copyright 2026 Mesa Orthobiologics File. This is general health education; it is not individual medical advice about a diagnosis or treatment choice.